Literature DB >> 24777637

Ubiquitous points of control over regulatory T cells.

Fan Pan1, Joseph Barbi.   

Abstract

Posttranslational modification by ubiquitin tagging is crucial for regulating the stability, activity and cellular localization of many target proteins involved in processes including DNA repair, cell cycle progression, protein quality control, and signal transduction. It has long been appreciated that ubiquitin-mediated events are important for certain signaling pathways leading to leukocyte activation and the stimulation of effector function. Now it is clear that the activities of molecules and pathways central to immune regulation are also modified and controlled by ubiquitin tagging. Among the mechanisms of immune control, regulatory T cells (or Tregs) are themselves particularly sensitive to such regulation. E3 ligases and deubiquitinases both influence Tregs through their effects on the signaling pathways pertinent to these cells or through the direct, posttranslational regulation of Foxp3. In this review, we will summarize and discuss several examples of ubiquitin-mediated control over multiple aspects of Treg biology including the generation, function and phenotypic fidelity of these cells. Fully explored and exploited, these potential opportunities for Treg modulation may lead to novel immunotherapies for both positive and negative fine-tuning of immune restraint.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777637      PMCID: PMC4083097          DOI: 10.1007/s00109-014-1156-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  150 in total

1.  Protein kinase C-theta mediates negative feedback on regulatory T cell function.

Authors:  Alexandra Zanin-Zhorov; Yi Ding; Sudha Kumari; Mukundan Attur; Keli L Hippen; Maryanne Brown; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

3.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

4.  TLR2 signaling improves immunoregulation to prevent type 1 diabetes.

Authors:  Christophe M Filippi; Katrin Ehrhardt; Elizabeth A Estes; Par Larsson; Janine E Oldham; Matthias G von Herrath
Journal:  Eur J Immunol       Date:  2011-05       Impact factor: 5.532

5.  Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth.

Authors:  Dong-Jun Peng; Minghui Zeng; Ryuta Muromoto; Tadashi Matsuda; Kazuya Shimoda; Malayannan Subramaniam; Thomas C Spelsberg; Wei-Zen Wei; K Venuprasad
Journal:  J Immunol       Date:  2011-04-06       Impact factor: 5.422

6.  Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival.

Authors:  N Zhang; B Krüger; G Lal; Y Luan; A Yadav; W Zang; M Grimm; A M Waaga-Gasser; B Murphy; J S Bromberg; B Schröppel
Journal:  Immunol Lett       Date:  2009-10-29       Impact factor: 3.685

7.  Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.

Authors:  Eric T Clambey; Eóin N McNamee; Joseph A Westrich; Louise E Glover; Eric L Campbell; Paul Jedlicka; Edwin F de Zoeten; John C Cambier; Kurt R Stenmark; Sean P Colgan; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

8.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.

Authors:  Jaime Darce; Dipayan Rudra; Li Li; Junko Nishio; Daniela Cipolletta; Alexander Y Rudensky; Diane Mathis; Christophe Benoist
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

9.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

10.  PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.

Authors:  Nikolaus Thuille; Katarzyna Wachowicz; Natascha Hermann-Kleiter; Sandra Kaminski; Friedrich Fresser; Christina Lutz-Nicoladoni; Michael Leitges; Margot Thome; Ramin Massoumi; Gottfried Baier
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  3 in total

Review 1.  Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment.

Authors:  Meera Murgai; Amber Giles; Rosandra Kaplan
Journal:  Crit Rev Oncog       Date:  2015

2.  Missed, Not Missing: Phylogenomic Evidence for the Existence of Avian FoxP3.

Authors:  Michael P Denyer; Dammy Y Pinheiro; Oliver A Garden; Adrian J Shepherd
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

3.  T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.

Authors:  Gloria J Godoy; Carolina Olivera; Daniela A Paira; Florencia C Salazar; Yamile Ana; Cinthia C Stempin; Ruben D Motrich; Virginia E Rivero
Journal:  Front Immunol       Date:  2019-11-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.